Body Recomposition: A Comprehensive and Metabolic Alternative to Weight Loss

《身體重組：一種全面且代謝的減重替代方案》提供了一種獨特的減重方法，透過身體重組強調在減少脂肪的同時增加肌肉。

Debasis Bagchi, PhD, MACN, CNS, CFFS, MAIChE, received his Ph.D. in Medicinal Chemistry in 1982. He is the Director of Scientific Affairs, VNI Inc., Bonita Springs, FL; an Adjunct Professor in College of Pharmacy and Health Sciences, Texas Southern University, Houston, TX; an Adjunct Faculty in the Department of Biology, Adelphi University, New York, NY, and an ex-Professor in the Department of Pharmacological and Pharmaceutical Sciences at the University of Houston College of Pharmacy, Houston, TX. He served as the Chief Scientific Officer at Cepham Inc, Belmont, NJ, from June 2013, till Dec 2018. He served as the Senior Vice President of Research & Development of InterHealth Nutraceuticals Inc, Benicia, CA, from 1998 till Feb 2011; Director of Innovation and Clinical Affairs, of Iovate Health Sciences, Oakville, ON, till June 2013; and then Chief Scientific Officer of Cepham Inc., Somerset. NJ. Dr. Bagchi is currently the Course Director and Instructor of a 3-Credit Hour Graduate Level Neurotoxicology BIO585 Course in the Department of Biology, Adelphi University, Garden City, New York, USA.

Dr. Bagchi received the Master of American College of Nutrition Award in October 2010 and became a Fellow of ISNFF in 2021. He is the Past Chairman of International Society of Nutraceuticals and Functional Foods (ISNFF), Past President of American College of Nutrition, Clearwater, FL, and Past Chair of the Nutraceuticals and Functional Foods Division of Institute of Food Technologists (IFT), Chicago, IL. He is serving as a Distinguished Advisor on the Japanese Institute for Health Food Standards (JIHFS), Tokyo, Japan. Dr. Bagchi is a Member of the Study Section and Peer Review Committee of the National Institutes of Health (NIH), Bethesda, MD. Dr. Bagchi has 415 papers in peer reviewed journals, 44 books and 20 patents. Dr. Bagchi is also a Member of the Society of Toxicology, Member of the New York Academy of Sciences, Fellow of the Nutrition Research Academy, and Member of the TCE stakeholder Committee of the Wright Patterson Air Force Base, OH. Dr. Bagchi is the Associate Editors of the Journal of Functional Foods, Journal of the American College of Nutrition, and Archives of Medical and Biomedical Research, and also serving as Editorial Board Member of numerous peer reviewed journals, including Antioxidants & Redox Signaling, Cancer Letters, Food & Nutrition Research, Toxicology Mechanisms and Methods, The Original Internist, and other peer reviewed journals.

Bernard William (Bill) Downs received his Bachelor of Science degree in 1975 from Pennsylvania State University. Downs simultaneously pursued his master's degree and Ph.D. in Nutrition and Biochemistry at Immaculata University in Immaculata, PA; advanced degree not completed. He became Director of Therapeutic Nutrition for Morrison Family and Sports Medicine, Huntingdon Valley, PA from 1990 till 1996. Downs served as the Director of Technical Sales for InterHealth Nutraceuticals Inc., Benicia, CA from 1990 till 2003. He was the Director of Research and Development for Allied Nutraceutical Research, Blue Bell, PA, from 2003 till 2008. Downs served as the CEO of LifeGen Research from 2009 till 2013, Lederach, PA. Downs is Founder and CEO of Victory Nutrition International, Inc., a Research & Development Biotech Company, Lederach, PA. Downs is a member of the American Association for the Advancement of Science, the American College of Nutrition, and past member of the NY Academy of Sciences. He is on the editorial review board of the Journal of Reward Deficiency Syndrome. Downs has authored or co-authored 105 papers published in peer-reviewed journals, numerous chapters in texts and handbooks for clinicians and researchers, with patents-pending in nutraceutical biotechnology. Research publications have been on issues ranging from immunity, anemia and metabolic disorders to addictions, obsessions, compulsions, and personality disorders, among other Reward Deficiency Syndrome conditions.

Dr. Sanjoy Chakraborty received his Ph.D. in Biochemistry from Calcutta University in 2001. He has a Masters in Biochemistry from Calcutta University, India. He is an Associate Professor at New York City College of Technology of City University of New York (CUNY). He teaches the Anatomy and Physiology and the Pathophysiology courses to students, mainly from health science majors (like Nursing, Dental Hygiene, and Radiology Technology). He is the coordinator of the Anatomy and Physiology I course. He has developed the Pathophysiology course (hybrid and online versions) and is the course coordinator. He has been a member of the departmental appointments committee since 2009. He also serves on the college council of the college. Dr.Chakraborty's teaching outreach goes beyond his classroom. He has actively participated in both research programs conducted by the college: Emerging Scholar Program and HonorsScholar Program. He mentored several students in biomedical research and trained them towrite, design, and present college poster presentations. He has published 25 research articles invarious peer-reviewed journals and more than 30 abstracts. He published several chapters in an invited book. His collaborations have enabled students of Citytech to conduct research outside the university and present in national and international meetings. Dr. Chakraborty serves as a reviewer of multiple journals. He has received GRTI grants, Perkins-VTEA Grant, and a few PSC-CUNY grants during his tenure at CUNY. Dr. Chakraborty is a member of the American Society of Biochemistry and Molecular Biology (ASBMB), and the Metropolitan Association of College and University Biologists (MACUB).

Dr. Tandra R. Chakraborty is currently the chair and professor of the biology department of Adelphi University, Garden City, New York. She received her BS (Honors), MS, and Ph. D. from the University of Calcutta. After completing her postdoctoral fellowship at Mount Sinai School of Medicine, she joined Adelphi University in 2006. She has served as a biology graduate director for six years. She has focused her career on helping students choose the career paths
that best suit their lives, personality, and characteristics and help them achieve success. She is passionate about bringing a change to the Adelphi community by instilling DEI in all and an equitable future.

Dr. Chakraborty has published about 30 scientific articles, several book chapters, and abstracts, and presented them in national and international meetings. She has developed a BS in Neuroscience and currently developing a BS. in Biomedical Sciences, both interdisciplinary programs at Adelphi University. She has advised over 300 students and mentored over 50undergraduate and graduate students. She has mentored several faculties and has hosted fundraising events. Dr. Chakraborty has chaired several departments, college, and university committees. She has received grants and established collaborations that help place students for internships. Dr. Chakraborty serves as a reviewer of many journals. She is invited to be the external reviewer of other departments/university's curricula and external evaluator for faculty going up for tenure and promotion.

Kenneth Blum is a well-known American Scientist recognized for his work related to Psychopharmacology and Psychiatric Genetics. He received a B. Sc. degree in Pharmaceutical Science from Columbia University (NYC); a Master's in Medicine from New Jersey College of Medicine (Rutgers) and a PhD in Neuropharmacology from New York Medical College. He is the recipient of many honors and awards including the Marquis Who's Who -Distinguished Top Professional to be featured in the Wall Street Journal. DR. Blum has published over 730 peer reviewed articles, book chapters and meeting abstracts with 17 books with over 17,000 citations and 185,000 reads worldwide. He has distinguished himself and is credited with the first genetic association of the Dopamine D2 receptor gene and severe alcoholism published in JAMA, 1990. He is considered by some to be the Father of Psychiatric Genetics. In1995, Dr. Blum coined the term "Reward Deficiency Syndrome (RDS)" and developed the USA and Foreign patented "Genetic Addiction Risk Severity" (GARS) test. Dr. Blum has also developed patented Pro-dopamine regulators in USA and Europe. His overall patent portfolio consists of 100 patents worldwide. Dr. Blum is the Editor -in-Chief on a number of academic journals including Current Psychopharmacology, addiction psychiatry, and Theranostic and Pharmacological Sciences. He also serves as Associate editor for Frontiers in Psychiatry and Frontiers in Public Health both related to the section on substance use disorder. He serves on 23 peer reviewed journals and is regional editor for Current Pharmaceutical & Biotechnology. His work has been featured in all the major media outlets worldwide and in 1990 his work on genetics was in the top 25 most important discoveries in science by Discovery Magazine. He is the recipient of NIH grants and has been awarded Lifetime Achievements, distinguished Honorary Doctors of Humane Letters; Life-time Honorary Professor at ELTE Eötvös Loránd University, Hungary and Distinguished Honorary Professor at Adelson School of Medicine, Ariel University, Israel. Currently, besides faculty positions as adjunct professor (Western University, University of Vermont, Wright School of Medicine), he is the Executive Chairman and CEO of TranspliceGen Therapeutics, Inc. Stanford university credited him as top 2% of the World Best scientist list (2023). Most recently the International Research Awards on Neurology and Neuro Disorders awarded him the "Best Researcher Award 2023".

Debasis Bagchi博士，MACN，CNS，CFFS，MAIChE，於1982年獲得藥物化學博士學位。他是VNI Inc.（位於佛羅里達州博尼塔泉）科學事務總監；德克薩斯南方大學（位於德克薩斯州休士頓）藥學與健康科學學院的兼任教授；阿德爾菲大學（位於紐約州紐約市）生物學系的兼任教員，以及休士頓大學藥學院藥理學與藥學科學系的前教授。他於2013年6月至2018年12月擔任Cepham Inc.（位於新澤西州貝爾蒙特）首席科學官；1998年至2011年2月擔任InterHealth Nutraceuticals Inc.（位於加州貝尼西亞）研究與開發高級副總裁；並於2013年6月之前擔任Iovate Health Sciences（位於加拿大安大略省奧克維爾）創新與臨床事務總監，隨後成為Cepham Inc.（位於新澤西州薩默塞特）首席科學官。Bagchi博士目前是阿德爾菲大學（位於紐約州花園城）生物學系的3學分研究生神經毒理學課程BIO585的課程主任和講師。

Bagchi博士於2010年10月獲得美國營養學院碩士獎，並於2021年成為ISNFF的院士。他曾擔任國際營養保健品與功能性食品學會（ISNFF）主席、美國營養學院（位於佛羅里達州克利爾沃特）前任會長，以及食品技術學會（IFT，位於伊利諾伊州芝加哥）營養保健品與功能性食品部門的前任主席。他目前擔任日本健康食品標準研究所（JIHFS，位於日本東京）的特別顧問。Bagchi博士是美國國立衛生研究院（NIH，位於馬里蘭州貝塞斯達）研究小組和同行評審委員會的成員。Bagchi博士在同行評審期刊上發表了415篇論文，出版了44本書籍和20項專利。他還是毒理學學會的成員、紐約科學院的成員、營養研究學院的院士，以及俄亥俄州萊特·帕特森空軍基地TCE利益相關者委員會的成員。Bagchi博士是《功能性食品期刊》、《美國營養學院期刊》和《醫學與生物醫學研究檔案》的副編輯，並擔任多本同行評審期刊的編輯委員會成員，包括《抗氧化劑與還原信號》、《癌症信件》、《食品與營養研究》、《毒理學機制與方法》、《原始內科醫生》等。

Bernard William (Bill) Downs於1975年獲得賓夕法尼亞州立大學的理學士學位。Downs同時在賓州伊瑪克拉大學攻讀營養學和生物化學的碩士及博士學位，但未完成進階學位。他於1990年至1996年擔任Morrison Family and Sports Medicine（位於賓州亨廷頓谷）治療營養總監。Downs於1990年至2003年擔任InterHealth Nutraceuticals Inc.（位於加州貝尼西亞）技術銷售總監；2003年至2008年擔任Allied Nutraceutical Research（位於賓州藍鐘）研究與開發總監；並於2009年至2013年擔任LifeGen Research（位於賓州萊德拉克）的首席執行官。Downs是Victory Nutrition International, Inc.的創始人及首席執行官，這是一家位於賓州萊德拉克的研究與開發生技公司。Downs是美國科學促進協會、美國營養學院的成員，並曾是紐約科學院的成員。他是《獎勵缺乏症候群期刊》的編輯審查委員會成員。Downs已發表或共同發表105篇同行評審期刊論文，並在臨床醫生和研究人員的多本教科書和手冊中撰寫了多個章節，並在營養保健品生物技術方面有專利申請。研究出版物涵蓋了從免疫、貧血和代謝疾病到成癮、強迫症和人格障礙等多個議題。